Your browser doesn't support javascript.
loading
IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus.
Zhao, Ming; Zhou, Yin; Zhu, Bochen; Wan, Mengjie; Jiang, Tingting; Tan, Qiqun; Liu, Yan; Jiang, Juqing; Luo, Shuaihantian; Tan, Yixin; Wu, Haijing; Renauer, Paul; Del Mar Ayala Gutiérrez, Maria; Castillo Palma, Maria Jesús; Ortega Castro, Rafaela; Fernández-Roldán, Concepción; Raya, Enrique; Faria, Raquel; Carvalho, Claudia; Alarcón-Riquelme, Marta E; Xiang, Zhongyuan; Chen, Jinwei; Li, Fen; Ling, Guanghui; Zhao, Hongjun; Liao, Xiangping; Lin, Youkun; Sawalha, Amr H; Lu, Qianjin.
Afiliación
  • Zhao M; Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Zhou Y; Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Zhu B; Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Wan M; Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Jiang T; Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Tan Q; Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Liu Y; Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Jiang J; Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Luo S; Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Tan Y; Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Wu H; Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Renauer P; Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Del Mar Ayala Gutiérrez M; Department of Internal Medicine, Hospital Universitario Carlos Haya, Málaga, Spain.
  • Castillo Palma MJ; Department of Internal Medicine, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Ortega Castro R; Servicio de Reumatología, Hospital Universitario Reina Sofía, Córdoba, Spain.
  • Fernández-Roldán C; Departament of Rheumatology, Unidad de Enfermedades Autoinmunes Sistémicas, Hospital Universitario San Cecilio, Granada, Spain.
  • Raya E; Departament of Rheumatology, Unidad de Enfermedades Autoinmunes Sistémicas, Hospital Universitario San Cecilio, Granada, Spain.
  • Faria R; Unidade de Imunologia Clínica/Centro Hospitalar do Porto, Porto, Portugal.
  • Carvalho C; Lab Imunogenetics & Autoimmu and NeuroScien, Unidade Multidisciplinar Invest Biomed, Inst Ciencias Biomed Abel Salazar/ Universidade do Porto, Porto, Portugal.
  • Alarcón-Riquelme ME; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA Centre for Genomics and Oncological Research (GENYO), Pfizer-University of Granada-Andalusian Regional Government, Health Sciences Technology Park, Granada, Spain.
  • Xiang Z; Department of Clinical Laboratory, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Chen J; Department of Rheumatology, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Li F; Department of Rheumatology, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Ling G; Department of Rheumatology, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Zhao H; Department of Rheumatology, Xiangya Hospital of Central South University, Changsha, China.
  • Liao X; Department of Nephropathy and Rheumatology, Chenzhou No.1 People's Hospital, Chenzhou, China.
  • Lin Y; Department of Dermatology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Sawalha AH; Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Lu Q; Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital of Central South University, Changsha, China.
Ann Rheum Dis ; 75(11): 1998-2006, 2016 Nov.
Article en En | MEDLINE | ID: mdl-26787370
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Regiones Promotoras Genéticas / Metilación de ADN / Proteínas del Citoesqueleto / Lupus Eritematoso Sistémico / Antígenos Tipo de estudio: Diagnostic_studies / Evaluation_studies / Observational_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Año: 2016 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Regiones Promotoras Genéticas / Metilación de ADN / Proteínas del Citoesqueleto / Lupus Eritematoso Sistémico / Antígenos Tipo de estudio: Diagnostic_studies / Evaluation_studies / Observational_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Año: 2016 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido